Monogram BioSciences - Test

Inflection Point: Going to market with a pioneering approach to personalized medicine.

Monogram BioSciences discovers, develops and markets innovative products to guide and improve treatment of serious infectious diseases and cancer. For Monogram, success required connecting with a number of key audiences with a compelling value proposition, including consumers, Big Pharma and investors. The new brand accomplishes this through a clean, confident visual approach that reassures all constituents that the company has the technology – and the business know-how – to deliver value.